| 0.7 |
2.7 |
GO:0021698 |
cerebellar cortex structural organization(GO:0021698) |
| 0.7 |
2.0 |
GO:0046959 |
habituation(GO:0046959) |
| 0.6 |
1.7 |
GO:0051902 |
negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
| 0.5 |
1.6 |
GO:0060489 |
establishment of body hair or bristle planar orientation(GO:0048104) establishment of body hair planar orientation(GO:0048105) orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060488) planar dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060489) lateral sprouting involved in lung morphogenesis(GO:0060490) |
| 0.5 |
1.5 |
GO:0072194 |
kidney smooth muscle tissue development(GO:0072194) |
| 0.5 |
1.5 |
GO:0015772 |
disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
| 0.5 |
2.4 |
GO:2000587 |
regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
| 0.5 |
1.4 |
GO:0060023 |
soft palate development(GO:0060023) |
| 0.4 |
1.2 |
GO:0086017 |
Purkinje myocyte action potential(GO:0086017) |
| 0.3 |
1.0 |
GO:0042271 |
susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
| 0.3 |
1.6 |
GO:0003199 |
endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
| 0.3 |
0.9 |
GO:0097623 |
potassium ion export across plasma membrane(GO:0097623) |
| 0.3 |
0.3 |
GO:0008626 |
granzyme-mediated apoptotic signaling pathway(GO:0008626) |
| 0.3 |
0.8 |
GO:0060478 |
acrosomal vesicle exocytosis(GO:0060478) |
| 0.3 |
1.7 |
GO:0021773 |
striatal medium spiny neuron differentiation(GO:0021773) |
| 0.3 |
0.8 |
GO:2000620 |
positive regulation of histone H4-K16 acetylation(GO:2000620) |
| 0.3 |
0.3 |
GO:0003096 |
renal sodium ion transport(GO:0003096) |
| 0.3 |
1.0 |
GO:0070829 |
heterochromatin maintenance(GO:0070829) |
| 0.2 |
0.7 |
GO:0030167 |
proteoglycan catabolic process(GO:0030167) |
| 0.2 |
1.2 |
GO:1900748 |
positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
| 0.2 |
2.0 |
GO:0044027 |
hypermethylation of CpG island(GO:0044027) |
| 0.2 |
0.2 |
GO:0036118 |
hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
| 0.2 |
0.9 |
GO:0065001 |
negative regulation of histone H3-K36 methylation(GO:0000415) specification of axis polarity(GO:0065001) |
| 0.2 |
1.2 |
GO:0070934 |
CRD-mediated mRNA stabilization(GO:0070934) |
| 0.2 |
3.5 |
GO:0007252 |
I-kappaB phosphorylation(GO:0007252) |
| 0.2 |
1.8 |
GO:0035608 |
protein deglutamylation(GO:0035608) |
| 0.2 |
0.7 |
GO:0097401 |
synaptic vesicle lumen acidification(GO:0097401) |
| 0.2 |
0.9 |
GO:0072061 |
inner medullary collecting duct development(GO:0072061) |
| 0.2 |
1.8 |
GO:0050882 |
voluntary musculoskeletal movement(GO:0050882) |
| 0.2 |
0.7 |
GO:0046022 |
regulation of transcription from RNA polymerase II promoter, mitotic(GO:0046021) positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) |
| 0.2 |
0.9 |
GO:0043974 |
histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
| 0.2 |
0.4 |
GO:1904058 |
positive regulation of sensory perception of pain(GO:1904058) |
| 0.2 |
0.4 |
GO:0003150 |
muscular septum morphogenesis(GO:0003150) |
| 0.2 |
0.6 |
GO:0060385 |
axonogenesis involved in innervation(GO:0060385) |
| 0.2 |
0.6 |
GO:0003349 |
epicardium-derived cardiac endothelial cell differentiation(GO:0003349) |
| 0.2 |
0.6 |
GO:0042323 |
negative regulation of circadian sleep/wake cycle, non-REM sleep(GO:0042323) negative regulation of mucus secretion(GO:0070256) |
| 0.2 |
0.8 |
GO:0003360 |
brainstem development(GO:0003360) |
| 0.2 |
0.2 |
GO:1904173 |
regulation of histone demethylase activity (H3-K4 specific)(GO:1904173) |
| 0.2 |
3.2 |
GO:0048617 |
embryonic foregut morphogenesis(GO:0048617) |
| 0.2 |
1.0 |
GO:0034436 |
glycoprotein transport(GO:0034436) |
| 0.2 |
0.6 |
GO:0043323 |
positive regulation of natural killer cell degranulation(GO:0043323) |
| 0.2 |
0.6 |
GO:0060010 |
Sertoli cell fate commitment(GO:0060010) |
| 0.2 |
2.6 |
GO:2000821 |
AMPA glutamate receptor clustering(GO:0097113) glutamate receptor clustering(GO:0097688) regulation of grooming behavior(GO:2000821) |
| 0.2 |
0.4 |
GO:0019401 |
alditol biosynthetic process(GO:0019401) |
| 0.2 |
1.4 |
GO:0070314 |
G1 to G0 transition(GO:0070314) |
| 0.2 |
1.1 |
GO:0006177 |
GMP biosynthetic process(GO:0006177) |
| 0.2 |
0.5 |
GO:2000344 |
positive regulation of acrosome reaction(GO:2000344) |
| 0.2 |
1.0 |
GO:0000320 |
re-entry into mitotic cell cycle(GO:0000320) |
| 0.2 |
1.2 |
GO:0021775 |
smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
| 0.2 |
0.7 |
GO:0016340 |
calcium-dependent cell-matrix adhesion(GO:0016340) |
| 0.2 |
0.3 |
GO:2000017 |
positive regulation of determination of dorsal identity(GO:2000017) |
| 0.2 |
0.5 |
GO:0046671 |
positive regulation of neuron maturation(GO:0014042) regulation of cellular pH reduction(GO:0032847) negative regulation of retinal cell programmed cell death(GO:0046671) |
| 0.2 |
0.7 |
GO:0010637 |
negative regulation of mitochondrial fusion(GO:0010637) |
| 0.2 |
0.5 |
GO:0009174 |
UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
| 0.2 |
1.7 |
GO:0021785 |
branchiomotor neuron axon guidance(GO:0021785) |
| 0.2 |
1.4 |
GO:0051967 |
negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
| 0.2 |
0.5 |
GO:0044337 |
canonical Wnt signaling pathway involved in positive regulation of apoptotic process(GO:0044337) |
| 0.2 |
1.1 |
GO:0031536 |
positive regulation of exit from mitosis(GO:0031536) |
| 0.2 |
0.8 |
GO:0031022 |
nuclear migration along microfilament(GO:0031022) |
| 0.1 |
0.4 |
GO:0018298 |
protein-chromophore linkage(GO:0018298) |
| 0.1 |
0.4 |
GO:0070844 |
misfolded protein transport(GO:0070843) polyubiquitinated protein transport(GO:0070844) polyubiquitinated misfolded protein transport(GO:0070845) Hsp90 deacetylation(GO:0070846) |
| 0.1 |
0.4 |
GO:0038003 |
opioid receptor signaling pathway(GO:0038003) regulation of opioid receptor signaling pathway(GO:2000474) |
| 0.1 |
0.6 |
GO:0021812 |
neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
| 0.1 |
0.3 |
GO:2000508 |
regulation of dendritic cell chemotaxis(GO:2000508) positive regulation of dendritic cell chemotaxis(GO:2000510) |
| 0.1 |
0.4 |
GO:0007403 |
glial cell fate determination(GO:0007403) |
| 0.1 |
0.4 |
GO:0009405 |
pathogenesis(GO:0009405) |
| 0.1 |
0.6 |
GO:0071596 |
ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
| 0.1 |
0.3 |
GO:0007621 |
negative regulation of female receptivity(GO:0007621) |
| 0.1 |
1.4 |
GO:0008063 |
Toll signaling pathway(GO:0008063) |
| 0.1 |
0.4 |
GO:0032696 |
negative regulation of interleukin-13 production(GO:0032696) odontoblast differentiation(GO:0071895) regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) |
| 0.1 |
0.1 |
GO:0061535 |
glutamate secretion, neurotransmission(GO:0061535) |
| 0.1 |
0.6 |
GO:0000160 |
phosphorelay signal transduction system(GO:0000160) |
| 0.1 |
0.4 |
GO:0045110 |
intermediate filament bundle assembly(GO:0045110) |
| 0.1 |
1.1 |
GO:1900262 |
regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 0.1 |
0.8 |
GO:0060017 |
parathyroid gland development(GO:0060017) |
| 0.1 |
0.1 |
GO:0007352 |
zygotic specification of dorsal/ventral axis(GO:0007352) |
| 0.1 |
0.7 |
GO:0007256 |
activation of JNKK activity(GO:0007256) |
| 0.1 |
1.2 |
GO:0097151 |
positive regulation of inhibitory postsynaptic potential(GO:0097151) |
| 0.1 |
0.7 |
GO:0072368 |
regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter(GO:0072368) |
| 0.1 |
1.7 |
GO:0071625 |
vocalization behavior(GO:0071625) |
| 0.1 |
0.4 |
GO:0035701 |
hematopoietic stem cell migration(GO:0035701) |
| 0.1 |
1.8 |
GO:0051764 |
actin crosslink formation(GO:0051764) |
| 0.1 |
0.3 |
GO:0010757 |
negative regulation of plasminogen activation(GO:0010757) |
| 0.1 |
0.4 |
GO:0070889 |
platelet alpha granule organization(GO:0070889) |
| 0.1 |
0.6 |
GO:0043314 |
negative regulation of neutrophil degranulation(GO:0043314) negative regulation of blood vessel remodeling(GO:0060313) |
| 0.1 |
0.2 |
GO:0021649 |
vestibulocochlear nerve morphogenesis(GO:0021648) vestibulocochlear nerve structural organization(GO:0021649) cerebral cortex tangential migration using cell-axon interactions(GO:0021824) gonadotrophin-releasing hormone neuronal migration to the hypothalamus(GO:0021828) hypothalamic tangential migration using cell-axon interactions(GO:0021856) ganglion morphogenesis(GO:0061552) facioacoustic ganglion development(GO:1903375) dorsal root ganglion morphogenesis(GO:1904835) |
| 0.1 |
1.6 |
GO:0048672 |
positive regulation of collateral sprouting(GO:0048672) |
| 0.1 |
0.6 |
GO:0006344 |
maintenance of chromatin silencing(GO:0006344) |
| 0.1 |
0.7 |
GO:0060371 |
regulation of atrial cardiac muscle cell membrane depolarization(GO:0060371) |
| 0.1 |
0.2 |
GO:0060024 |
rhythmic synaptic transmission(GO:0060024) |
| 0.1 |
0.4 |
GO:0060022 |
hard palate development(GO:0060022) |
| 0.1 |
1.4 |
GO:0061302 |
smooth muscle cell-matrix adhesion(GO:0061302) |
| 0.1 |
0.4 |
GO:0032053 |
ciliary basal body organization(GO:0032053) |
| 0.1 |
0.6 |
GO:0070345 |
negative regulation of fat cell proliferation(GO:0070345) |
| 0.1 |
0.5 |
GO:0043973 |
histone H3-K4 acetylation(GO:0043973) |
| 0.1 |
0.5 |
GO:0010668 |
ectodermal cell differentiation(GO:0010668) |
| 0.1 |
0.7 |
GO:0030644 |
cellular chloride ion homeostasis(GO:0030644) |
| 0.1 |
0.2 |
GO:0007386 |
compartment pattern specification(GO:0007386) |
| 0.1 |
0.3 |
GO:0006597 |
spermine biosynthetic process(GO:0006597) |
| 0.1 |
0.5 |
GO:0072675 |
osteoclast fusion(GO:0072675) |
| 0.1 |
0.1 |
GO:0072553 |
terminal button organization(GO:0072553) |
| 0.1 |
0.8 |
GO:0001842 |
neural fold formation(GO:0001842) |
| 0.1 |
0.3 |
GO:0016191 |
synaptic vesicle uncoating(GO:0016191) regulation of endosome organization(GO:1904978) positive regulation of endosome organization(GO:1904980) |
| 0.1 |
0.2 |
GO:0060853 |
arterial endothelial cell fate commitment(GO:0060844) blood vessel endothelial cell fate commitment(GO:0060846) endothelial cell fate specification(GO:0060847) Notch signaling pathway involved in arterial endothelial cell fate commitment(GO:0060853) blood vessel endothelial cell fate specification(GO:0097101) |
| 0.1 |
1.8 |
GO:0080182 |
histone H3-K4 trimethylation(GO:0080182) |
| 0.1 |
0.3 |
GO:0001978 |
regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback(GO:0001978) |
| 0.1 |
0.3 |
GO:0060244 |
negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
| 0.1 |
0.1 |
GO:1901536 |
regulation of DNA demethylation(GO:1901535) negative regulation of DNA demethylation(GO:1901536) |
| 0.1 |
0.3 |
GO:0098528 |
terpenoid catabolic process(GO:0016115) skeletal muscle fiber differentiation(GO:0098528) |
| 0.1 |
0.4 |
GO:0034454 |
microtubule anchoring at centrosome(GO:0034454) |
| 0.1 |
0.7 |
GO:0001977 |
renal system process involved in regulation of blood volume(GO:0001977) |
| 0.1 |
1.1 |
GO:0001956 |
positive regulation of neurotransmitter secretion(GO:0001956) |
| 0.1 |
0.5 |
GO:0015803 |
branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
| 0.1 |
0.4 |
GO:1904529 |
regulation of actin filament binding(GO:1904529) regulation of actin binding(GO:1904616) |
| 0.1 |
0.4 |
GO:0061110 |
dense core granule biogenesis(GO:0061110) regulation of dense core granule biogenesis(GO:2000705) |
| 0.1 |
0.2 |
GO:1902172 |
keratinocyte apoptotic process(GO:0097283) regulation of keratinocyte apoptotic process(GO:1902172) |
| 0.1 |
0.2 |
GO:0046985 |
positive regulation of hemoglobin biosynthetic process(GO:0046985) |
| 0.1 |
0.7 |
GO:0061092 |
regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
| 0.1 |
0.5 |
GO:0051387 |
negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
| 0.1 |
1.9 |
GO:0061029 |
eyelid development in camera-type eye(GO:0061029) |
| 0.1 |
0.4 |
GO:1903251 |
multi-ciliated epithelial cell differentiation(GO:1903251) |
| 0.1 |
0.4 |
GO:1904565 |
response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
| 0.1 |
0.4 |
GO:1900740 |
regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
| 0.1 |
0.2 |
GO:0009957 |
epidermal cell fate specification(GO:0009957) |
| 0.1 |
0.8 |
GO:0035542 |
regulation of SNARE complex assembly(GO:0035542) |
| 0.1 |
0.8 |
GO:0038031 |
non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
| 0.1 |
0.7 |
GO:0072321 |
chaperone-mediated protein transport(GO:0072321) |
| 0.1 |
0.3 |
GO:1903423 |
positive regulation of synaptic vesicle transport(GO:1902805) positive regulation of synaptic vesicle recycling(GO:1903423) |
| 0.1 |
1.5 |
GO:1900454 |
positive regulation of long term synaptic depression(GO:1900454) |
| 0.1 |
0.3 |
GO:0070459 |
prolactin secretion(GO:0070459) |
| 0.1 |
0.4 |
GO:0003365 |
establishment of cell polarity involved in ameboidal cell migration(GO:0003365) |
| 0.1 |
0.3 |
GO:0014005 |
microglia differentiation(GO:0014004) microglia development(GO:0014005) |
| 0.1 |
0.3 |
GO:0021849 |
neuroblast division in subventricular zone(GO:0021849) |
| 0.1 |
0.7 |
GO:0061368 |
behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
| 0.1 |
0.4 |
GO:0035606 |
peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
| 0.1 |
0.5 |
GO:0030643 |
cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
| 0.1 |
0.4 |
GO:0051643 |
endoplasmic reticulum localization(GO:0051643) |
| 0.1 |
0.3 |
GO:0048686 |
regulation of sprouting of injured axon(GO:0048686) regulation of axon extension involved in regeneration(GO:0048690) |
| 0.1 |
0.5 |
GO:0014886 |
transition between slow and fast fiber(GO:0014886) |
| 0.1 |
0.3 |
GO:0032229 |
negative regulation of synaptic transmission, GABAergic(GO:0032229) |
| 0.1 |
0.3 |
GO:1901731 |
calcium-mediated signaling using extracellular calcium source(GO:0035585) positive regulation of platelet aggregation(GO:1901731) |
| 0.1 |
0.2 |
GO:1900736 |
regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) |
| 0.1 |
0.1 |
GO:0043201 |
response to leucine(GO:0043201) cellular response to leucine(GO:0071233) |
| 0.1 |
0.3 |
GO:0060399 |
positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
| 0.1 |
0.3 |
GO:1903406 |
regulation of sodium:potassium-exchanging ATPase activity(GO:1903406) |
| 0.1 |
0.4 |
GO:0060059 |
embryonic retina morphogenesis in camera-type eye(GO:0060059) |
| 0.1 |
0.5 |
GO:0060347 |
heart trabecula formation(GO:0060347) |
| 0.1 |
0.4 |
GO:0060050 |
positive regulation of protein glycosylation(GO:0060050) |
| 0.1 |
1.0 |
GO:0060065 |
uterus development(GO:0060065) |
| 0.1 |
0.3 |
GO:0016561 |
protein import into peroxisome matrix, translocation(GO:0016561) |
| 0.1 |
0.1 |
GO:0090238 |
positive regulation of arachidonic acid secretion(GO:0090238) |
| 0.1 |
0.3 |
GO:0019676 |
ammonia assimilation cycle(GO:0019676) |
| 0.1 |
0.4 |
GO:0006680 |
glucosylceramide catabolic process(GO:0006680) |
| 0.1 |
0.4 |
GO:0051823 |
regulation of synapse structural plasticity(GO:0051823) |
| 0.1 |
0.7 |
GO:0006477 |
protein sulfation(GO:0006477) |
| 0.1 |
0.3 |
GO:0051295 |
establishment of meiotic spindle localization(GO:0051295) |
| 0.1 |
0.3 |
GO:1903265 |
positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
| 0.1 |
0.4 |
GO:1903553 |
positive regulation of extracellular exosome assembly(GO:1903553) |
| 0.1 |
0.3 |
GO:1903715 |
regulation of aerobic respiration(GO:1903715) |
| 0.1 |
0.3 |
GO:0060912 |
cardiac cell fate specification(GO:0060912) |
| 0.1 |
0.2 |
GO:0060060 |
post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
| 0.1 |
0.4 |
GO:1902534 |
single-organism membrane invagination(GO:1902534) |
| 0.1 |
0.5 |
GO:0048170 |
positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
| 0.1 |
0.2 |
GO:2000393 |
negative regulation of lamellipodium morphogenesis(GO:2000393) |
| 0.1 |
0.2 |
GO:0045085 |
negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
| 0.1 |
0.4 |
GO:0000972 |
transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
| 0.1 |
0.6 |
GO:0035330 |
regulation of hippo signaling(GO:0035330) |
| 0.1 |
0.2 |
GO:1901187 |
regulation of ephrin receptor signaling pathway(GO:1901187) |
| 0.1 |
0.2 |
GO:1900126 |
negative regulation of hyaluronan biosynthetic process(GO:1900126) |
| 0.1 |
0.1 |
GO:0031133 |
regulation of axon diameter(GO:0031133) |
| 0.1 |
0.5 |
GO:0051798 |
positive regulation of hair follicle development(GO:0051798) |
| 0.1 |
0.4 |
GO:1900042 |
positive regulation of interleukin-2 secretion(GO:1900042) |
| 0.1 |
0.2 |
GO:0007223 |
Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
| 0.1 |
0.2 |
GO:0070933 |
histone H4 deacetylation(GO:0070933) |
| 0.1 |
0.6 |
GO:1904417 |
regulation of xenophagy(GO:1904415) positive regulation of xenophagy(GO:1904417) |
| 0.1 |
0.2 |
GO:0042908 |
xenobiotic transport(GO:0042908) |
| 0.1 |
0.4 |
GO:0090527 |
actin filament reorganization(GO:0090527) |
| 0.1 |
0.1 |
GO:0048388 |
endosomal lumen acidification(GO:0048388) |
| 0.1 |
0.4 |
GO:0071476 |
cellular hypotonic response(GO:0071476) |
| 0.1 |
0.2 |
GO:0090271 |
positive regulation of fibroblast growth factor production(GO:0090271) |
| 0.1 |
0.6 |
GO:0006620 |
posttranslational protein targeting to membrane(GO:0006620) |
| 0.1 |
0.2 |
GO:0002669 |
positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
| 0.1 |
0.4 |
GO:0072318 |
clathrin coat disassembly(GO:0072318) |
| 0.1 |
0.2 |
GO:0072610 |
interleukin-12 secretion(GO:0072610) regulation of interleukin-12 secretion(GO:2001182) positive regulation of interleukin-12 secretion(GO:2001184) |
| 0.1 |
0.1 |
GO:0071649 |
regulation of chemokine (C-C motif) ligand 5 production(GO:0071649) |
| 0.1 |
0.6 |
GO:0036506 |
maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
| 0.1 |
0.4 |
GO:0035507 |
regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
| 0.1 |
0.3 |
GO:0072344 |
rescue of stalled ribosome(GO:0072344) |
| 0.1 |
0.1 |
GO:0036515 |
serotonergic neuron axon guidance(GO:0036515) |
| 0.1 |
0.4 |
GO:0035087 |
siRNA loading onto RISC involved in RNA interference(GO:0035087) |
| 0.1 |
0.7 |
GO:0090232 |
positive regulation of spindle checkpoint(GO:0090232) |
| 0.1 |
0.1 |
GO:0061188 |
regulation of chromatin silencing at rDNA(GO:0061187) negative regulation of chromatin silencing at rDNA(GO:0061188) |
| 0.1 |
1.3 |
GO:0051127 |
positive regulation of actin nucleation(GO:0051127) |
| 0.1 |
0.3 |
GO:0097393 |
post-embryonic appendage morphogenesis(GO:0035120) post-embryonic limb morphogenesis(GO:0035127) post-embryonic forelimb morphogenesis(GO:0035128) telomeric repeat-containing RNA transcription(GO:0097393) telomeric repeat-containing RNA transcription from RNA pol II promoter(GO:0097394) regulation of telomeric RNA transcription from RNA pol II promoter(GO:1901580) negative regulation of telomeric RNA transcription from RNA pol II promoter(GO:1901581) positive regulation of telomeric RNA transcription from RNA pol II promoter(GO:1901582) |
| 0.1 |
0.5 |
GO:0036072 |
intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
| 0.1 |
1.0 |
GO:0007216 |
G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
| 0.1 |
0.5 |
GO:0015675 |
nickel cation transport(GO:0015675) |
| 0.1 |
0.6 |
GO:0060272 |
embryonic skeletal joint morphogenesis(GO:0060272) |
| 0.1 |
0.7 |
GO:0060136 |
embryonic process involved in female pregnancy(GO:0060136) |
| 0.1 |
0.2 |
GO:1901165 |
positive regulation of trophoblast cell migration(GO:1901165) |
| 0.1 |
0.7 |
GO:0033292 |
T-tubule organization(GO:0033292) |
| 0.1 |
0.5 |
GO:0048742 |
regulation of skeletal muscle fiber development(GO:0048742) |
| 0.1 |
0.7 |
GO:0015732 |
prostaglandin transport(GO:0015732) |
| 0.1 |
0.3 |
GO:0001865 |
NK T cell differentiation(GO:0001865) regulation of NK T cell differentiation(GO:0051136) positive regulation of NK T cell differentiation(GO:0051138) |
| 0.1 |
0.3 |
GO:0048341 |
paraxial mesoderm formation(GO:0048341) |
| 0.1 |
2.8 |
GO:0006284 |
base-excision repair(GO:0006284) |
| 0.1 |
0.5 |
GO:0019227 |
neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
| 0.1 |
0.3 |
GO:0060836 |
lymphatic endothelial cell differentiation(GO:0060836) |
| 0.1 |
0.2 |
GO:0042264 |
peptidyl-aspartic acid hydroxylation(GO:0042264) |
| 0.1 |
1.0 |
GO:0016339 |
calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
| 0.1 |
0.4 |
GO:0007296 |
vitellogenesis(GO:0007296) |
| 0.1 |
0.3 |
GO:0030718 |
germ-line stem cell population maintenance(GO:0030718) |
| 0.1 |
0.4 |
GO:1904707 |
positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
| 0.1 |
0.4 |
GO:0006452 |
translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
| 0.1 |
0.1 |
GO:0034334 |
adherens junction maintenance(GO:0034334) |
| 0.1 |
0.1 |
GO:0060298 |
positive regulation of sarcomere organization(GO:0060298) |
| 0.1 |
0.4 |
GO:0090179 |
planar cell polarity pathway involved in neural tube closure(GO:0090179) |
| 0.1 |
0.5 |
GO:0086036 |
regulation of cardiac muscle cell membrane potential(GO:0086036) |
| 0.1 |
0.2 |
GO:0046836 |
glycolipid transport(GO:0046836) |
| 0.1 |
0.5 |
GO:0009404 |
toxin metabolic process(GO:0009404) |
| 0.1 |
0.5 |
GO:0021830 |
interneuron migration from the subpallium to the cortex(GO:0021830) |
| 0.1 |
0.5 |
GO:0033564 |
anterior/posterior axon guidance(GO:0033564) |
| 0.1 |
0.2 |
GO:1900365 |
positive regulation of mRNA polyadenylation(GO:1900365) |
| 0.1 |
0.4 |
GO:0010764 |
negative regulation of fibroblast migration(GO:0010764) |
| 0.1 |
1.8 |
GO:0007520 |
myoblast fusion(GO:0007520) |
| 0.1 |
0.4 |
GO:0043569 |
negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
| 0.1 |
0.2 |
GO:0042998 |
positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
| 0.1 |
0.4 |
GO:0045647 |
negative regulation of erythrocyte differentiation(GO:0045647) |
| 0.1 |
0.5 |
GO:0042989 |
sequestering of actin monomers(GO:0042989) |
| 0.1 |
0.3 |
GO:0043567 |
regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
| 0.1 |
0.2 |
GO:0002645 |
positive regulation of tolerance induction(GO:0002645) |
| 0.1 |
0.1 |
GO:2000832 |
negative regulation of steroid hormone secretion(GO:2000832) negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
| 0.1 |
0.2 |
GO:0002184 |
cytoplasmic translational termination(GO:0002184) |
| 0.1 |
0.6 |
GO:0045956 |
positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
| 0.1 |
0.6 |
GO:0048386 |
positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
| 0.1 |
0.2 |
GO:0045806 |
negative regulation of endocytosis(GO:0045806) |
| 0.1 |
0.2 |
GO:0036091 |
positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
| 0.1 |
0.2 |
GO:0007290 |
spermatid nucleus elongation(GO:0007290) |
| 0.1 |
1.1 |
GO:0043403 |
skeletal muscle tissue regeneration(GO:0043403) |
| 0.1 |
0.5 |
GO:0071257 |
cellular response to electrical stimulus(GO:0071257) |
| 0.1 |
0.3 |
GO:1903961 |
positive regulation of plasma membrane long-chain fatty acid transport(GO:0010747) positive regulation of anion transmembrane transport(GO:1903961) |
| 0.1 |
0.1 |
GO:0021626 |
hindbrain maturation(GO:0021578) central nervous system maturation(GO:0021626) |
| 0.1 |
0.5 |
GO:0061000 |
negative regulation of dendritic spine development(GO:0061000) |
| 0.1 |
0.1 |
GO:2000297 |
negative regulation of synapse maturation(GO:2000297) |
| 0.1 |
0.2 |
GO:0035063 |
nuclear speck organization(GO:0035063) |
| 0.1 |
1.5 |
GO:0007608 |
sensory perception of smell(GO:0007608) |
| 0.1 |
0.3 |
GO:0035726 |
common myeloid progenitor cell proliferation(GO:0035726) |
| 0.1 |
0.4 |
GO:1900025 |
negative regulation of substrate adhesion-dependent cell spreading(GO:1900025) |
| 0.1 |
0.2 |
GO:0050925 |
negative regulation of negative chemotaxis(GO:0050925) |
| 0.1 |
0.1 |
GO:0014028 |
notochord formation(GO:0014028) |
| 0.1 |
0.4 |
GO:2001224 |
positive regulation of neuron migration(GO:2001224) |
| 0.1 |
0.8 |
GO:0070935 |
3'-UTR-mediated mRNA stabilization(GO:0070935) |
| 0.1 |
0.7 |
GO:0003334 |
keratinocyte development(GO:0003334) |
| 0.1 |
0.4 |
GO:0051014 |
actin filament severing(GO:0051014) |
| 0.1 |
0.7 |
GO:0021684 |
cerebellar granular layer morphogenesis(GO:0021683) cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
| 0.1 |
0.1 |
GO:0001543 |
ovarian follicle rupture(GO:0001543) |
| 0.1 |
0.4 |
GO:1904217 |
regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 0.1 |
0.9 |
GO:2000369 |
regulation of clathrin-mediated endocytosis(GO:2000369) |
| 0.1 |
0.4 |
GO:0048172 |
regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 0.1 |
0.2 |
GO:0001830 |
trophectodermal cell fate commitment(GO:0001830) |
| 0.1 |
0.2 |
GO:1901097 |
negative regulation of autophagosome maturation(GO:1901097) |
| 0.1 |
0.1 |
GO:0098910 |
regulation of atrial cardiac muscle cell action potential(GO:0098910) |
| 0.1 |
0.2 |
GO:0046341 |
CDP-diacylglycerol metabolic process(GO:0046341) |
| 0.1 |
0.2 |
GO:0070164 |
negative regulation of adiponectin secretion(GO:0070164) |
| 0.1 |
0.2 |
GO:0097278 |
complement-dependent cytotoxicity(GO:0097278) |
| 0.1 |
0.2 |
GO:0018103 |
protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
| 0.1 |
0.1 |
GO:0002035 |
brain renin-angiotensin system(GO:0002035) |
| 0.1 |
0.2 |
GO:0042536 |
negative regulation of tumor necrosis factor biosynthetic process(GO:0042536) |
| 0.1 |
0.2 |
GO:1904017 |
response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
| 0.1 |
0.1 |
GO:0060129 |
thyroid-stimulating hormone-secreting cell differentiation(GO:0060129) |
| 0.1 |
0.4 |
GO:0048681 |
negative regulation of axon regeneration(GO:0048681) |
| 0.1 |
1.0 |
GO:2000311 |
regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
| 0.0 |
0.1 |
GO:0071880 |
adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
| 0.0 |
0.0 |
GO:0051963 |
regulation of synapse assembly(GO:0051963) |
| 0.0 |
0.4 |
GO:0019240 |
citrulline biosynthetic process(GO:0019240) |
| 0.0 |
0.8 |
GO:0090136 |
epithelial cell-cell adhesion(GO:0090136) |
| 0.0 |
0.4 |
GO:0071225 |
cellular response to muramyl dipeptide(GO:0071225) |
| 0.0 |
0.1 |
GO:2000822 |
regulation of fear response(GO:1903365) regulation of behavioral fear response(GO:2000822) |
| 0.0 |
0.3 |
GO:1902414 |
protein localization to cell junction(GO:1902414) |
| 0.0 |
0.0 |
GO:0070094 |
positive regulation of glucagon secretion(GO:0070094) |
| 0.0 |
0.3 |
GO:0046543 |
development of secondary female sexual characteristics(GO:0046543) |
| 0.0 |
0.9 |
GO:0031103 |
axon regeneration(GO:0031103) |
| 0.0 |
0.3 |
GO:1903056 |
regulation of lens fiber cell differentiation(GO:1902746) positive regulation of lens fiber cell differentiation(GO:1902748) regulation of melanosome organization(GO:1903056) |
| 0.0 |
0.2 |
GO:0035426 |
extracellular matrix-cell signaling(GO:0035426) |
| 0.0 |
0.8 |
GO:0061462 |
protein localization to lysosome(GO:0061462) |
| 0.0 |
0.7 |
GO:0007530 |
sex determination(GO:0007530) |
| 0.0 |
0.0 |
GO:1900452 |
regulation of long term synaptic depression(GO:1900452) |
| 0.0 |
0.1 |
GO:0060373 |
regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
| 0.0 |
0.4 |
GO:0070932 |
histone H3 deacetylation(GO:0070932) |
| 0.0 |
0.1 |
GO:0033364 |
endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) mast cell secretory granule organization(GO:0033364) |
| 0.0 |
0.2 |
GO:0099515 |
actin filament-based transport(GO:0099515) |
| 0.0 |
0.1 |
GO:0021764 |
amygdala development(GO:0021764) |
| 0.0 |
0.3 |
GO:2000786 |
positive regulation of autophagosome assembly(GO:2000786) |
| 0.0 |
0.1 |
GO:0007158 |
neuron cell-cell adhesion(GO:0007158) |
| 0.0 |
0.6 |
GO:0001833 |
inner cell mass cell proliferation(GO:0001833) |
| 0.0 |
0.2 |
GO:1903378 |
positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
| 0.0 |
0.3 |
GO:0070561 |
vitamin D receptor signaling pathway(GO:0070561) |
| 0.0 |
0.3 |
GO:0060052 |
neurofilament cytoskeleton organization(GO:0060052) |
| 0.0 |
0.2 |
GO:0060999 |
positive regulation of dendritic spine development(GO:0060999) |
| 0.0 |
0.5 |
GO:0048096 |
chromatin-mediated maintenance of transcription(GO:0048096) |
| 0.0 |
0.4 |
GO:0006415 |
translational termination(GO:0006415) |
| 0.0 |
0.2 |
GO:1901724 |
positive regulation of cell proliferation involved in kidney development(GO:1901724) |
| 0.0 |
0.1 |
GO:1902995 |
regulation of phospholipid efflux(GO:1902994) positive regulation of phospholipid efflux(GO:1902995) |
| 0.0 |
0.3 |
GO:1903300 |
negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
| 0.0 |
0.0 |
GO:2001270 |
regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
| 0.0 |
0.3 |
GO:0045721 |
negative regulation of gluconeogenesis(GO:0045721) |
| 0.0 |
0.1 |
GO:0048296 |
isotype switching to IgA isotypes(GO:0048290) regulation of isotype switching to IgA isotypes(GO:0048296) |
| 0.0 |
0.1 |
GO:0045659 |
regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
| 0.0 |
0.1 |
GO:0007379 |
segment specification(GO:0007379) |
| 0.0 |
0.0 |
GO:0014735 |
regulation of muscle atrophy(GO:0014735) |
| 0.0 |
0.7 |
GO:0001967 |
suckling behavior(GO:0001967) |
| 0.0 |
0.2 |
GO:0032485 |
regulation of Ral protein signal transduction(GO:0032485) |
| 0.0 |
0.1 |
GO:0036092 |
phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
| 0.0 |
0.2 |
GO:2001025 |
positive regulation of response to drug(GO:2001025) |
| 0.0 |
0.2 |
GO:0071947 |
protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
| 0.0 |
0.5 |
GO:0048484 |
enteric nervous system development(GO:0048484) |
| 0.0 |
0.8 |
GO:0016486 |
peptide hormone processing(GO:0016486) |
| 0.0 |
0.3 |
GO:2000270 |
negative regulation of fibroblast apoptotic process(GO:2000270) |
| 0.0 |
0.1 |
GO:0039530 |
MDA-5 signaling pathway(GO:0039530) |
| 0.0 |
0.2 |
GO:0000185 |
activation of MAPKKK activity(GO:0000185) |
| 0.0 |
0.1 |
GO:0036509 |
trimming of terminal mannose on B branch(GO:0036509) |
| 0.0 |
0.1 |
GO:0002667 |
lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) |
| 0.0 |
0.3 |
GO:0097369 |
sodium ion import(GO:0097369) sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
| 0.0 |
0.4 |
GO:0030322 |
stabilization of membrane potential(GO:0030322) |
| 0.0 |
0.8 |
GO:0070208 |
protein heterotrimerization(GO:0070208) |
| 0.0 |
0.4 |
GO:2001197 |
regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
| 0.0 |
0.1 |
GO:0035795 |
negative regulation of mitochondrial membrane permeability(GO:0035795) |
| 0.0 |
0.1 |
GO:0036500 |
ATF6-mediated unfolded protein response(GO:0036500) |
| 0.0 |
0.3 |
GO:0045719 |
negative regulation of glycogen biosynthetic process(GO:0045719) negative regulation of glycogen metabolic process(GO:0070874) |
| 0.0 |
0.9 |
GO:0045494 |
photoreceptor cell maintenance(GO:0045494) |
| 0.0 |
0.3 |
GO:1901250 |
regulation of lung goblet cell differentiation(GO:1901249) negative regulation of lung goblet cell differentiation(GO:1901250) |
| 0.0 |
0.2 |
GO:0048149 |
behavioral response to ethanol(GO:0048149) |
| 0.0 |
0.1 |
GO:0048211 |
Golgi vesicle docking(GO:0048211) |
| 0.0 |
0.3 |
GO:0007190 |
activation of adenylate cyclase activity(GO:0007190) |
| 0.0 |
0.3 |
GO:0060736 |
prostate gland growth(GO:0060736) |
| 0.0 |
0.1 |
GO:1900220 |
semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
| 0.0 |
0.1 |
GO:0002182 |
cytoplasmic translational elongation(GO:0002182) regulation of cytoplasmic translational elongation(GO:1900247) negative regulation of cytoplasmic translational elongation(GO:1900248) |
| 0.0 |
0.5 |
GO:0042492 |
gamma-delta T cell differentiation(GO:0042492) |
| 0.0 |
0.0 |
GO:0034729 |
histone H3-K79 methylation(GO:0034729) |
| 0.0 |
0.1 |
GO:0090315 |
negative regulation of protein targeting to membrane(GO:0090315) |
| 0.0 |
0.2 |
GO:0021993 |
initiation of neural tube closure(GO:0021993) |
| 0.0 |
0.1 |
GO:0060279 |
positive regulation of ovulation(GO:0060279) |
| 0.0 |
0.3 |
GO:0046541 |
saliva secretion(GO:0046541) |
| 0.0 |
0.2 |
GO:0043951 |
negative regulation of cAMP-mediated signaling(GO:0043951) |
| 0.0 |
0.1 |
GO:0006428 |
isoleucyl-tRNA aminoacylation(GO:0006428) |
| 0.0 |
0.1 |
GO:0030432 |
peristalsis(GO:0030432) |
| 0.0 |
0.4 |
GO:0007220 |
Notch receptor processing(GO:0007220) |
| 0.0 |
0.1 |
GO:0015015 |
heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
| 0.0 |
0.1 |
GO:0060693 |
regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
| 0.0 |
0.1 |
GO:2000811 |
negative regulation of anoikis(GO:2000811) |
| 0.0 |
0.4 |
GO:0032808 |
lacrimal gland development(GO:0032808) |
| 0.0 |
0.2 |
GO:0008343 |
adult feeding behavior(GO:0008343) |
| 0.0 |
0.3 |
GO:0034377 |
plasma lipoprotein particle assembly(GO:0034377) |
| 0.0 |
0.1 |
GO:1901837 |
negative regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901837) |
| 0.0 |
0.1 |
GO:0048162 |
preantral ovarian follicle growth(GO:0001546) multi-layer follicle stage(GO:0048162) |
| 0.0 |
0.2 |
GO:0098734 |
protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
| 0.0 |
0.5 |
GO:2000052 |
positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
| 0.0 |
0.1 |
GO:0033326 |
cerebrospinal fluid secretion(GO:0033326) |
| 0.0 |
0.2 |
GO:0031547 |
brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
| 0.0 |
0.1 |
GO:0045743 |
positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
| 0.0 |
0.1 |
GO:1903551 |
regulation of extracellular exosome assembly(GO:1903551) |
| 0.0 |
0.1 |
GO:0048520 |
positive regulation of behavior(GO:0048520) |
| 0.0 |
0.1 |
GO:1900227 |
positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
| 0.0 |
0.2 |
GO:0090399 |
replicative senescence(GO:0090399) |
| 0.0 |
0.1 |
GO:0045924 |
negative regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0017055) regulation of female receptivity(GO:0045924) positive regulation of female receptivity(GO:0045925) |
| 0.0 |
0.1 |
GO:0032803 |
low-density lipoprotein particle receptor catabolic process(GO:0032802) regulation of low-density lipoprotein particle receptor catabolic process(GO:0032803) |
| 0.0 |
0.4 |
GO:0002076 |
osteoblast development(GO:0002076) |
| 0.0 |
0.1 |
GO:0090383 |
phagosome acidification(GO:0090383) |
| 0.0 |
0.4 |
GO:0002091 |
negative regulation of receptor internalization(GO:0002091) |
| 0.0 |
0.2 |
GO:0038032 |
termination of G-protein coupled receptor signaling pathway(GO:0038032) |
| 0.0 |
0.1 |
GO:0000389 |
mRNA 3'-splice site recognition(GO:0000389) |
| 0.0 |
0.5 |
GO:0045761 |
regulation of adenylate cyclase activity(GO:0045761) |
| 0.0 |
0.0 |
GO:0070858 |
negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
| 0.0 |
0.1 |
GO:0007128 |
meiotic prophase I(GO:0007128) prophase(GO:0051324) meiotic cell cycle phase(GO:0098762) meiosis I cell cycle phase(GO:0098764) |
| 0.0 |
0.3 |
GO:0006607 |
NLS-bearing protein import into nucleus(GO:0006607) |
| 0.0 |
0.5 |
GO:0048169 |
regulation of long-term neuronal synaptic plasticity(GO:0048169) |
| 0.0 |
0.0 |
GO:0071374 |
cellular response to parathyroid hormone stimulus(GO:0071374) |
| 0.0 |
0.1 |
GO:0019249 |
lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
| 0.0 |
0.2 |
GO:0010025 |
wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
| 0.0 |
0.7 |
GO:0048011 |
neurotrophin TRK receptor signaling pathway(GO:0048011) |
| 0.0 |
0.3 |
GO:0000059 |
protein import into nucleus, docking(GO:0000059) |
| 0.0 |
0.6 |
GO:0043968 |
histone H2A acetylation(GO:0043968) |
| 0.0 |
0.1 |
GO:0048069 |
eye pigmentation(GO:0048069) |
| 0.0 |
0.1 |
GO:0019355 |
nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
| 0.0 |
0.1 |
GO:0010739 |
positive regulation of protein kinase A signaling(GO:0010739) |
| 0.0 |
0.5 |
GO:0071364 |
cellular response to epidermal growth factor stimulus(GO:0071364) |
| 0.0 |
0.1 |
GO:0097119 |
postsynaptic density protein 95 clustering(GO:0097119) |
| 0.0 |
0.1 |
GO:0071376 |
response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
| 0.0 |
0.1 |
GO:0051045 |
negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
| 0.0 |
0.1 |
GO:0070166 |
enamel mineralization(GO:0070166) |
| 0.0 |
1.5 |
GO:1902017 |
regulation of cilium assembly(GO:1902017) |
| 0.0 |
0.6 |
GO:0046856 |
phosphatidylinositol dephosphorylation(GO:0046856) |
| 0.0 |
0.2 |
GO:0033148 |
positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
| 0.0 |
0.1 |
GO:0019236 |
response to pheromone(GO:0019236) |
| 0.0 |
0.1 |
GO:1901096 |
regulation of autophagosome maturation(GO:1901096) |
| 0.0 |
0.6 |
GO:0045604 |
regulation of epidermal cell differentiation(GO:0045604) |
| 0.0 |
0.1 |
GO:0061245 |
establishment or maintenance of apical/basal cell polarity(GO:0035088) establishment or maintenance of bipolar cell polarity(GO:0061245) |
| 0.0 |
0.1 |
GO:1902528 |
regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
| 0.0 |
0.9 |
GO:0051973 |
positive regulation of telomerase activity(GO:0051973) |
| 0.0 |
0.0 |
GO:0006701 |
progesterone biosynthetic process(GO:0006701) |
| 0.0 |
0.2 |
GO:0045056 |
transcytosis(GO:0045056) |
| 0.0 |
0.1 |
GO:0072592 |
oxygen metabolic process(GO:0072592) |
| 0.0 |
0.2 |
GO:0048251 |
elastic fiber assembly(GO:0048251) |
| 0.0 |
0.2 |
GO:0090073 |
positive regulation of protein homodimerization activity(GO:0090073) |
| 0.0 |
0.4 |
GO:0006677 |
glycosylceramide metabolic process(GO:0006677) |
| 0.0 |
0.5 |
GO:0061001 |
regulation of dendritic spine morphogenesis(GO:0061001) |
| 0.0 |
0.3 |
GO:2000480 |
negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
| 0.0 |
0.1 |
GO:1904354 |
negative regulation of telomere capping(GO:1904354) |
| 0.0 |
0.1 |
GO:0003433 |
chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
| 0.0 |
0.1 |
GO:1902358 |
sulfate transmembrane transport(GO:1902358) |
| 0.0 |
0.0 |
GO:0043691 |
reverse cholesterol transport(GO:0043691) |
| 0.0 |
0.2 |
GO:0001963 |
synaptic transmission, dopaminergic(GO:0001963) |
| 0.0 |
0.1 |
GO:0060462 |
lung lobe development(GO:0060462) lung lobe morphogenesis(GO:0060463) |
| 0.0 |
0.1 |
GO:0021886 |
hypothalamus gonadotrophin-releasing hormone neuron differentiation(GO:0021886) hypothalamus gonadotrophin-releasing hormone neuron development(GO:0021888) |
| 0.0 |
0.1 |
GO:0060267 |
positive regulation of respiratory burst(GO:0060267) |
| 0.0 |
0.3 |
GO:0001553 |
luteinization(GO:0001553) |
| 0.0 |
0.0 |
GO:0010986 |
positive regulation of lipoprotein particle clearance(GO:0010986) |
| 0.0 |
0.0 |
GO:0043490 |
malate-aspartate shuttle(GO:0043490) |
| 0.0 |
0.1 |
GO:0003420 |
regulation of growth plate cartilage chondrocyte proliferation(GO:0003420) |
| 0.0 |
0.1 |
GO:0060037 |
pharyngeal system development(GO:0060037) |
| 0.0 |
0.3 |
GO:0009438 |
methylglyoxal metabolic process(GO:0009438) |
| 0.0 |
1.0 |
GO:0060395 |
SMAD protein signal transduction(GO:0060395) |
| 0.0 |
1.5 |
GO:0010923 |
negative regulation of phosphatase activity(GO:0010923) |
| 0.0 |
0.3 |
GO:0043154 |
negative regulation of cysteine-type endopeptidase activity involved in apoptotic process(GO:0043154) negative regulation of cysteine-type endopeptidase activity(GO:2000117) |
| 0.0 |
0.2 |
GO:0072643 |
interferon-gamma secretion(GO:0072643) |
| 0.0 |
0.3 |
GO:0030213 |
hyaluronan biosynthetic process(GO:0030213) |
| 0.0 |
0.0 |
GO:1903334 |
positive regulation of protein folding(GO:1903334) |
| 0.0 |
0.3 |
GO:0021535 |
cell migration in hindbrain(GO:0021535) |
| 0.0 |
0.1 |
GO:0070914 |
UV-damage excision repair(GO:0070914) |
| 0.0 |
0.2 |
GO:0070445 |
oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) |
| 0.0 |
0.0 |
GO:0021559 |
trigeminal nerve development(GO:0021559) |
| 0.0 |
0.1 |
GO:0097186 |
amelogenesis(GO:0097186) |
| 0.0 |
0.2 |
GO:0035020 |
regulation of Rac protein signal transduction(GO:0035020) |
| 0.0 |
0.0 |
GO:0036508 |
protein deglycosylation involved in glycoprotein catabolic process(GO:0035977) protein demannosylation(GO:0036507) protein alpha-1,2-demannosylation(GO:0036508) mannose trimming involved in glycoprotein ERAD pathway(GO:1904382) |
| 0.0 |
0.4 |
GO:0006085 |
acetyl-CoA biosynthetic process(GO:0006085) |
| 0.0 |
0.1 |
GO:0030579 |
ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
| 0.0 |
1.0 |
GO:0055013 |
cardiac muscle cell development(GO:0055013) |
| 0.0 |
0.0 |
GO:1903599 |
positive regulation of mitophagy(GO:1903599) |
| 0.0 |
0.1 |
GO:0000350 |
generation of catalytic spliceosome for second transesterification step(GO:0000350) |
| 0.0 |
0.1 |
GO:0042866 |
pyruvate biosynthetic process(GO:0042866) D-amino acid metabolic process(GO:0046416) |
| 0.0 |
0.1 |
GO:0006741 |
NADP biosynthetic process(GO:0006741) |
| 0.0 |
0.0 |
GO:0015825 |
L-serine transport(GO:0015825) |
| 0.0 |
0.2 |
GO:0021957 |
corticospinal tract morphogenesis(GO:0021957) |
| 0.0 |
0.1 |
GO:0001828 |
inner cell mass cell fate commitment(GO:0001827) inner cell mass cellular morphogenesis(GO:0001828) |
| 0.0 |
0.6 |
GO:2000573 |
positive regulation of DNA biosynthetic process(GO:2000573) |
| 0.0 |
0.1 |
GO:0033690 |
positive regulation of osteoblast proliferation(GO:0033690) |
| 0.0 |
0.1 |
GO:0008298 |
intracellular mRNA localization(GO:0008298) |
| 0.0 |
0.2 |
GO:0070544 |
histone H3-K36 demethylation(GO:0070544) |
| 0.0 |
0.0 |
GO:0002315 |
marginal zone B cell differentiation(GO:0002315) |
| 0.0 |
0.1 |
GO:0016322 |
neuron remodeling(GO:0016322) |
| 0.0 |
0.2 |
GO:2000009 |
negative regulation of protein localization to cell surface(GO:2000009) |
| 0.0 |
0.7 |
GO:0036075 |
endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
| 0.0 |
0.1 |
GO:0033540 |
fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
| 0.0 |
0.2 |
GO:0006398 |
mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 0.0 |
0.4 |
GO:0035335 |
peptidyl-tyrosine dephosphorylation(GO:0035335) |
| 0.0 |
0.2 |
GO:0061179 |
negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
| 0.0 |
0.1 |
GO:0030576 |
Cajal body organization(GO:0030576) |
| 0.0 |
0.2 |
GO:0048661 |
positive regulation of smooth muscle cell proliferation(GO:0048661) |
| 0.0 |
0.1 |
GO:0071394 |
cellular response to testosterone stimulus(GO:0071394) |
| 0.0 |
0.2 |
GO:0060159 |
regulation of dopamine receptor signaling pathway(GO:0060159) |
| 0.0 |
0.1 |
GO:0042138 |
meiotic DNA double-strand break formation(GO:0042138) |
| 0.0 |
0.1 |
GO:0097039 |
protein linear polyubiquitination(GO:0097039) |
| 0.0 |
0.1 |
GO:0000965 |
mitochondrial RNA 3'-end processing(GO:0000965) |
| 0.0 |
0.0 |
GO:0015920 |
lipopolysaccharide transport(GO:0015920) |
| 0.0 |
0.1 |
GO:2000781 |
positive regulation of double-strand break repair(GO:2000781) |
| 0.0 |
0.1 |
GO:0061430 |
bone trabecula morphogenesis(GO:0061430) |
| 0.0 |
0.4 |
GO:0045760 |
positive regulation of action potential(GO:0045760) |
| 0.0 |
0.1 |
GO:0046602 |
regulation of mitotic centrosome separation(GO:0046602) |
| 0.0 |
0.1 |
GO:0090244 |
Wnt signaling pathway involved in somitogenesis(GO:0090244) |
| 0.0 |
0.2 |
GO:0097094 |
craniofacial suture morphogenesis(GO:0097094) |
| 0.0 |
0.1 |
GO:0048505 |
regulation of timing of cell differentiation(GO:0048505) |
| 0.0 |
0.3 |
GO:0061577 |
calcium ion transmembrane transport via high voltage-gated calcium channel(GO:0061577) |
| 0.0 |
0.1 |
GO:0009414 |
response to water deprivation(GO:0009414) |
| 0.0 |
0.1 |
GO:0060266 |
negative regulation of respiratory burst involved in inflammatory response(GO:0060266) negative regulation of respiratory burst(GO:0060268) |
| 0.0 |
0.1 |
GO:0046709 |
IDP metabolic process(GO:0046707) IDP catabolic process(GO:0046709) |
| 0.0 |
0.3 |
GO:1903861 |
regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
| 0.0 |
0.0 |
GO:1903377 |
negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
| 0.0 |
0.1 |
GO:0006987 |
activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
| 0.0 |
0.1 |
GO:0060907 |
positive regulation of macrophage cytokine production(GO:0060907) |
| 0.0 |
0.0 |
GO:0035898 |
parathyroid hormone secretion(GO:0035898) |
| 0.0 |
0.0 |
GO:0010499 |
proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
| 0.0 |
0.0 |
GO:0033280 |
response to vitamin D(GO:0033280) |
| 0.0 |
0.6 |
GO:0007032 |
endosome organization(GO:0007032) |
| 0.0 |
0.1 |
GO:0072383 |
plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
| 0.0 |
0.1 |
GO:0010724 |
regulation of definitive erythrocyte differentiation(GO:0010724) |
| 0.0 |
0.1 |
GO:0045723 |
positive regulation of fatty acid biosynthetic process(GO:0045723) |
| 0.0 |
0.2 |
GO:0045974 |
miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
| 0.0 |
0.1 |
GO:1900533 |
medium-chain fatty-acyl-CoA catabolic process(GO:0036114) fatty-acyl-CoA catabolic process(GO:0036115) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
| 0.0 |
0.1 |
GO:0032693 |
negative regulation of interleukin-10 production(GO:0032693) |
| 0.0 |
0.4 |
GO:0005980 |
polysaccharide catabolic process(GO:0000272) glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
| 0.0 |
0.1 |
GO:0008635 |
activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
| 0.0 |
0.0 |
GO:0033700 |
phospholipid efflux(GO:0033700) |
| 0.0 |
0.1 |
GO:0072137 |
condensed mesenchymal cell proliferation(GO:0072137) |
| 0.0 |
0.1 |
GO:0006995 |
cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 0.0 |
0.1 |
GO:2000491 |
positive regulation of hepatic stellate cell activation(GO:2000491) |
| 0.0 |
0.1 |
GO:0090042 |
tubulin deacetylation(GO:0090042) |
| 0.0 |
0.1 |
GO:0051534 |
negative regulation of NFAT protein import into nucleus(GO:0051534) |
| 0.0 |
0.1 |
GO:0034773 |
histone H4-K20 trimethylation(GO:0034773) |
| 0.0 |
0.1 |
GO:0010830 |
regulation of myotube differentiation(GO:0010830) |
| 0.0 |
0.1 |
GO:0060854 |
patterning of lymph vessels(GO:0060854) |
| 0.0 |
0.1 |
GO:0007625 |
grooming behavior(GO:0007625) |
| 0.0 |
0.0 |
GO:0000715 |
nucleotide-excision repair, DNA damage recognition(GO:0000715) |
| 0.0 |
0.2 |
GO:0010388 |
protein deneddylation(GO:0000338) cullin deneddylation(GO:0010388) |
| 0.0 |
0.3 |
GO:0048026 |
positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
| 0.0 |
0.0 |
GO:0048312 |
intracellular distribution of mitochondria(GO:0048312) |
| 0.0 |
0.2 |
GO:0010793 |
regulation of mRNA export from nucleus(GO:0010793) regulation of ribonucleoprotein complex localization(GO:2000197) |
| 0.0 |
0.1 |
GO:0018401 |
peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
| 0.0 |
0.1 |
GO:0032439 |
endosome localization(GO:0032439) |
| 0.0 |
0.0 |
GO:0007398 |
ectoderm development(GO:0007398) |
| 0.0 |
0.1 |
GO:0031937 |
positive regulation of chromatin silencing(GO:0031937) |
| 0.0 |
0.0 |
GO:0042347 |
negative regulation of NF-kappaB import into nucleus(GO:0042347) |
| 0.0 |
0.3 |
GO:0033006 |
regulation of mast cell activation involved in immune response(GO:0033006) regulation of mast cell degranulation(GO:0043304) |
| 0.0 |
0.2 |
GO:0060122 |
inner ear receptor stereocilium organization(GO:0060122) |
| 0.0 |
0.3 |
GO:0046329 |
negative regulation of JNK cascade(GO:0046329) |
| 0.0 |
0.1 |
GO:0031119 |
tRNA pseudouridine synthesis(GO:0031119) |
| 0.0 |
0.1 |
GO:0006278 |
RNA-dependent DNA biosynthetic process(GO:0006278) telomere maintenance via telomerase(GO:0007004) |
| 0.0 |
0.3 |
GO:0045197 |
establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
| 0.0 |
0.3 |
GO:0019835 |
cytolysis(GO:0019835) |
| 0.0 |
0.0 |
GO:0033574 |
response to testosterone(GO:0033574) |
| 0.0 |
0.0 |
GO:0086018 |
SA node cell action potential(GO:0086015) SA node cell to atrial cardiac muscle cell signalling(GO:0086018) SA node cell to atrial cardiac muscle cell communication(GO:0086070) |
| 0.0 |
0.0 |
GO:0007171 |
activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
| 0.0 |
0.2 |
GO:0007638 |
mechanosensory behavior(GO:0007638) |
| 0.0 |
0.1 |
GO:0035886 |
vascular smooth muscle cell differentiation(GO:0035886) |
| 0.0 |
0.2 |
GO:0030819 |
positive regulation of cAMP metabolic process(GO:0030816) positive regulation of cAMP biosynthetic process(GO:0030819) |
| 0.0 |
0.2 |
GO:0006012 |
galactose metabolic process(GO:0006012) |
| 0.0 |
0.1 |
GO:0031145 |
anaphase-promoting complex-dependent catabolic process(GO:0031145) |
| 0.0 |
0.2 |
GO:0032528 |
microvillus organization(GO:0032528) |
| 0.0 |
0.2 |
GO:0035510 |
DNA dealkylation(GO:0035510) |
| 0.0 |
0.1 |
GO:0071281 |
cellular response to iron ion(GO:0071281) |
| 0.0 |
0.2 |
GO:0007064 |
mitotic sister chromatid cohesion(GO:0007064) |
| 0.0 |
0.2 |
GO:0060292 |
long term synaptic depression(GO:0060292) |
| 0.0 |
0.3 |
GO:0015813 |
L-glutamate transport(GO:0015813) |
| 0.0 |
0.1 |
GO:1900194 |
negative regulation of oocyte development(GO:0060283) negative regulation of oocyte maturation(GO:1900194) |
| 0.0 |
0.2 |
GO:0002335 |
mature B cell differentiation(GO:0002335) |
| 0.0 |
0.1 |
GO:0035308 |
negative regulation of dephosphorylation(GO:0035305) negative regulation of protein dephosphorylation(GO:0035308) |
| 0.0 |
0.2 |
GO:0014047 |
glutamate secretion(GO:0014047) |
| 0.0 |
0.1 |
GO:0045022 |
early endosome to late endosome transport(GO:0045022) |
| 0.0 |
0.1 |
GO:0043252 |
sodium-independent organic anion transport(GO:0043252) |
| 0.0 |
0.1 |
GO:0006654 |
phosphatidic acid biosynthetic process(GO:0006654) phosphatidic acid metabolic process(GO:0046473) |
| 0.0 |
0.0 |
GO:0006020 |
inositol metabolic process(GO:0006020) |
| 0.0 |
0.1 |
GO:0007189 |
adenylate cyclase-activating G-protein coupled receptor signaling pathway(GO:0007189) |
| 0.0 |
0.1 |
GO:0042790 |
transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:0042790) |
| 0.0 |
0.0 |
GO:0034472 |
snRNA 3'-end processing(GO:0034472) |
| 0.0 |
0.1 |
GO:0043921 |
modulation by host of viral transcription(GO:0043921) modulation of transcription in other organism involved in symbiotic interaction(GO:0052312) modulation by host of symbiont transcription(GO:0052472) |
| 0.0 |
0.1 |
GO:0055012 |
ventricular cardiac muscle cell differentiation(GO:0055012) |
| 0.0 |
0.1 |
GO:0046069 |
cGMP catabolic process(GO:0046069) |
| 0.0 |
0.0 |
GO:0019085 |
early viral transcription(GO:0019085) |
| 0.0 |
0.0 |
GO:0061042 |
vascular wound healing(GO:0061042) |
| 0.0 |
0.1 |
GO:0010800 |
positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
| 0.0 |
0.1 |
GO:0033120 |
positive regulation of RNA splicing(GO:0033120) |
| 0.0 |
0.0 |
GO:0090494 |
catecholamine uptake(GO:0090493) dopamine uptake(GO:0090494) |
| 0.0 |
0.1 |
GO:0003094 |
glomerular filtration(GO:0003094) |
| 0.0 |
0.2 |
GO:0015693 |
magnesium ion transport(GO:0015693) |
| 0.0 |
0.1 |
GO:0051684 |
maintenance of Golgi location(GO:0051684) |
| 0.0 |
0.0 |
GO:0048102 |
autophagic cell death(GO:0048102) |
| 0.0 |
0.1 |
GO:0007258 |
JUN phosphorylation(GO:0007258) |
| 0.0 |
0.1 |
GO:0090435 |
protein localization to nuclear envelope(GO:0090435) |
| 0.0 |
0.0 |
GO:0060068 |
vagina development(GO:0060068) |
| 0.0 |
0.1 |
GO:0042304 |
regulation of fatty acid biosynthetic process(GO:0042304) |
| 0.0 |
0.1 |
GO:0007253 |
cytoplasmic sequestering of NF-kappaB(GO:0007253) |
| 0.0 |
0.1 |
GO:0006687 |
glycosphingolipid metabolic process(GO:0006687) |
| 0.0 |
0.0 |
GO:0042796 |
snRNA transcription from RNA polymerase III promoter(GO:0042796) |
| 0.0 |
0.1 |
GO:0036158 |
outer dynein arm assembly(GO:0036158) |
| 0.0 |
0.1 |
GO:0090074 |
negative regulation of protein homodimerization activity(GO:0090074) |
| 0.0 |
0.1 |
GO:0046726 |
positive regulation by virus of viral protein levels in host cell(GO:0046726) |
| 0.0 |
0.1 |
GO:0034497 |
protein localization to pre-autophagosomal structure(GO:0034497) |
| 0.0 |
0.1 |
GO:0090084 |
negative regulation of inclusion body assembly(GO:0090084) |
| 0.0 |
0.2 |
GO:0099517 |
anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
| 0.0 |
0.1 |
GO:0061615 |
glycolytic process through fructose-6-phosphate(GO:0061615) |
| 0.0 |
0.2 |
GO:0006353 |
DNA-templated transcription, termination(GO:0006353) |
| 0.0 |
0.1 |
GO:0010992 |
ubiquitin homeostasis(GO:0010992) |
| 0.0 |
0.0 |
GO:0042822 |
vitamin B6 metabolic process(GO:0042816) pyridoxal phosphate metabolic process(GO:0042822) pyridoxal phosphate biosynthetic process(GO:0042823) |
| 0.0 |
0.2 |
GO:0000186 |
activation of MAPKK activity(GO:0000186) |
| 0.0 |
0.1 |
GO:0050892 |
intestinal absorption(GO:0050892) |
| 0.0 |
0.1 |
GO:0000132 |
establishment of mitotic spindle orientation(GO:0000132) |
| 0.0 |
0.0 |
GO:1900028 |
negative regulation of ruffle assembly(GO:1900028) |
| 0.0 |
0.1 |
GO:0032897 |
negative regulation of viral transcription(GO:0032897) |
| 0.0 |
0.2 |
GO:0071353 |
response to interleukin-4(GO:0070670) cellular response to interleukin-4(GO:0071353) |
| 0.0 |
0.1 |
GO:0035067 |
negative regulation of histone acetylation(GO:0035067) |
| 0.0 |
0.0 |
GO:0019287 |
isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) isopentenyl diphosphate metabolic process(GO:0046490) |
| 0.0 |
0.2 |
GO:0006879 |
cellular iron ion homeostasis(GO:0006879) |
| 0.0 |
0.2 |
GO:0045214 |
sarcomere organization(GO:0045214) |
| 0.0 |
0.2 |
GO:0034389 |
lipid particle organization(GO:0034389) |
| 0.0 |
0.0 |
GO:0097167 |
circadian regulation of translation(GO:0097167) |
| 0.0 |
0.1 |
GO:0090164 |
asymmetric Golgi ribbon formation(GO:0090164) |
| 0.0 |
0.0 |
GO:0010989 |
negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
| 0.0 |
0.0 |
GO:0002636 |
positive regulation of germinal center formation(GO:0002636) |
| 0.0 |
0.1 |
GO:0016601 |
Rac protein signal transduction(GO:0016601) |
| 0.0 |
0.0 |
GO:0060392 |
negative regulation of SMAD protein import into nucleus(GO:0060392) |
| 0.0 |
0.1 |
GO:0014912 |
negative regulation of smooth muscle cell migration(GO:0014912) |
| 0.0 |
0.1 |
GO:0034720 |
histone H3-K4 demethylation(GO:0034720) |
| 0.0 |
0.2 |
GO:1902254 |
negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902254) |
| 0.0 |
0.1 |
GO:0006337 |
nucleosome disassembly(GO:0006337) protein-DNA complex disassembly(GO:0032986) |
| 0.0 |
0.1 |
GO:0090308 |
regulation of methylation-dependent chromatin silencing(GO:0090308) |
| 0.0 |
0.1 |
GO:0001829 |
trophectodermal cell differentiation(GO:0001829) |
| 0.0 |
0.0 |
GO:1902416 |
positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
| 0.0 |
0.2 |
GO:0045540 |
regulation of cholesterol biosynthetic process(GO:0045540) |
| 0.0 |
0.0 |
GO:1904251 |
regulation of bile acid metabolic process(GO:1904251) |
| 0.0 |
0.1 |
GO:0010259 |
multicellular organism aging(GO:0010259) |
| 0.0 |
0.2 |
GO:0042832 |
defense response to protozoan(GO:0042832) |
| 0.0 |
0.3 |
GO:0006783 |
heme biosynthetic process(GO:0006783) |
| 0.0 |
0.0 |
GO:0072015 |
glomerular visceral epithelial cell development(GO:0072015) glomerular epithelial cell development(GO:0072310) |
| 0.0 |
0.1 |
GO:0006517 |
protein deglycosylation(GO:0006517) |
| 0.0 |
0.1 |
GO:0014807 |
regulation of somitogenesis(GO:0014807) |
| 0.0 |
0.1 |
GO:1900037 |
regulation of cellular response to hypoxia(GO:1900037) |
